Fig. 3From: Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidenceForest plot of reported hazard ratios for risk of breast cancer among insulin glargine users. RCT randomized controlled trialBack to article page
